Navigation Links
sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
Date:4/28/2011

able to equity holders of sanofi-aventisMillions of eurosQ1 2011Q1 2010(1)

% changeBusiness net income2,1702,427(10.6%)Amortization of intangible assets(2)

(736)

(848)Impairment of intangible assets

(32)Fair value remeasurement of contingent

consideration liabilities

(46)Expenses arising from the impact of acquisitions on inventories

(2)

(62)Restructuring costs

(122)

(167)Other gains and losses, and litigation(3)

(517)Discontinuation of depreciation of PP&E* (IFRS5)18Tax effect of :

510

349Amortization of intangible assets

263

282Impairment of intangible assets

10Expenses arising on the workdown of acquired inventories17Restructuring costs

42

56Other gains and losses, and litigation

195Discontinuation of depreciation of PP&E (IFRS5)*(6)Other tax items4Restructuring costs of associates and joint ventures, and expenses arising from the impact of acquisitions on associates and joint ventures

(7)

(7)Net income attributable to equity holders of sanofi-aventis1,2181,714(28.9%)Consolidated earnings per share(4) (in euros)0.931.31(29.0%)(1) the results of operations of the Merial business previously presented as "held-for-exchange" were reclassified and included in income from continuing operations in accordance with IFRS5 section 36, following the announcement to maintain Merial and Intervet/Schering-Plough as two separate organizations.(2) Of which amortization expense generated by the remeasurement of intangible assets as part of business  combinations: euro  686 million in the first quarter of 2011 and euro  801 million in the first quarter of 2010.(3) In 2011: non-recurring amortization charge in respect of 2009 and 2010 depreciation and amortization expense on PP&E* and intangible assets
'/>"/>

SOURCE sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
2. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
3. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
4. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
8. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
9. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
10. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
11. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" or ... announced financial results for its first quarter ended December ... ended December 31, 2014, revenue was $1,336,685. Operating expenses ... or $0.02 per share.  Covalon,s President ... very pleased with the significant progress we have made ...
(Date:2/27/2015)... SAN DIEGO , Feb. 27, 2015 /PRNewswire/ ... three-dimensional biology company focused on delivering breakthrough 3D ... , President and Chief Executive Officer, will present ... "We invite you to join us for ... to provide updates on our commercial launch of ...
(Date:2/27/2015)... MINNEAPOLIS , Feb. 27, 2015  Uroplasty, Inc. (NASDAQ: ... develops, manufactures and markets innovative proprietary products to treat ... the 27th Annual ROTH Conference on Tuesday, March 10, ... Brett Reynolds , Chief Financial Officer, will present ... one on one at the conference at the Ritz ...
Breaking Medicine Technology:Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4Uroplasty to Participate in the 27th Annual ROTH Conference 2
... Technology is revolutionizing healthcare — making it more ... cost of care. AT&T ,s* new set of ... designed to do just that. The 2011 Frost & ... AT&T for its approach to mHealth, recognizing the company,s ...
... -- GC-Rise Pharmaceutical Co. Ltd, in which European healthcare ... recently listed as one of the Deloitte & Touche,s ... growth over the past three years. Beijing-headquartered ... its operating revenues rising more than 270% on average ...
Cached Medicine Technology:Frost and Sullivan Recognizes AT&T's Innovative mHealth Strategy 2Frost and Sullivan Recognizes AT&T's Innovative mHealth Strategy 3Frost and Sullivan Recognizes AT&T's Innovative mHealth Strategy 4Women Health Expert GC-Rise Listed in Deloitte's 50 Top-performing Companies 2
(Date:3/2/2015)... 02, 2015 ProvidaStaff has ... its educational healthcare division to EDU Healthcare ... services to school systems and students nationwide. , “ProvidaStaff ... school districts throughout the country,” said Angela M. Lewis, ... a better organization and the introduction of EDU Healthcare ...
(Date:3/2/2015)... 02, 2015 Final Cut Pro X ... Volume 2 from Pixel Film Studios. , “The TranStatic Volume ... FCPX,” said Christina Austin, CEO of Pixel Film Studios. “TranStatic ... Final Cut Pro X editors toolbox.” , With TranStatic Volume ... with media altering static scrambling effects from Pixel Film Studios. ...
(Date:3/1/2015)... Clearwater, Florida (PRWEB) March 02, 2015 ... market their services and manage their practices ... offer an integrated all-inclusive solution. The ... development program and a medical practice management ... success and long-term financial sustainability. A referral ...
(Date:3/1/2015)... As residents and business owners in Southlake, Texas, ... Weaver, believe in supporting local organizations and causes. ... of Commerce, Carroll Independent School District and numerous ... for Southlake mayoral candidate Laura Hill: http://www.LauraHillforSouthlake.com ... campaign, the website combines images, videos and interactive ...
(Date:3/1/2015)... Birmingham, Clarkston, Lake Orion, Metamora, Michigan (PRWEB) March 01, 2015 ... BOTOX® , which is approved to treat Overactive Bladder (OAB) ... urgency and frequency in adults when another type of medication ... This is a different treatment option that takes another ... itself. , BOTOX® works on the nerves and ...
Breaking Medicine News(10 mins):Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 2Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 3Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2
... New England Journal of Medicine reports the latest research ... crossed in treating early breast //cancer successfully after having ... studies apparently looked into the effectiveness of adding the ... in early stages of breast cancer. Both studies ...
... Breast Cancer Campaign charity yesterday suggested that breast cancer may ... a long-term manageable disorder like diabetes and arthritis. ... to the significant developments in the diagnosis and treatment of ... recurrence of the cancer was reduced by new drugs like ...
... less inclined to commit suicide as compared to Whites was ... among black Americans. Scientists from the University of Michigan said ... ones own life happens to be the 11th leading cause ... that nearly one in 10 black Americans suffer from suicidal ...
... of coffee (3 cups a day) can affect a man's ... to show the adverse effect of modern life on the ... the US govt. has shown that modern men have only ... hampster (160 million/ml). The sperm count has declined worldwide over ...
... More than two-thirds of people who suffer from major ... work with their doctors //and try various treatments to ... taking different antidepressants or adding cognitive therapy to the ... led by UT Southwestern Medical Center, found that 67 ...
... According to British scientists, symptoms of schizophrenia can be ... Imperial College London conducted a study in 4 hospitals ... when they were encouraged to express themselves through music. ... psychological treatments can help people with schizophrenia, but these ...
Cached Medicine News:Health News:Breast Cancer may no longer be a killer disease 2Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 2Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 3
... Bausch & Lomb PreserVision® AREDS formula ... and mineral supplement clinically proven effective in ... Age Related Eye Disease Study (AREDS). , ... and mineral supplement with the antioxidant vitamins ...
Ocuvite® vitamin and mineral supplements contain 2 mg of Lutein 8 times more than the leading multivitamins. Ocuvite also contains vitamin antioxidants A, C and E, as well as the minerals zinc, ...
HydroEye is an exclusive formulation designed to provide dry eye relief and support the body's natural tear formation. Like all ScienceBased Health formulations, it is produced in softgel form for ma...
Easy-to-use desktop QC data management solution...
Medicine Products: